Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial‑mesenchymal transition in lung adenocarcinoma-Reference-Cited by-同舟云学术

Origin recognition complex 1 regulates phospholipase Cδ1 to inhibit cell proliferation, migration and epithelial‑mesenchymal transition in lung adenocarcinoma

Published:2022-06-10 Issue:2 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Jian Yao¹,Qiao Qing²,Tang Juanjuan³,Qin Xiaobing³

Affiliation:

1. Department of Respiratory Medicine, Public Health Clinical Center of Chengdu, Chengdu, Sichuan 610041, P.R. China

2. Department of Oncology, People's Hospital of Leshan, Leshan, Sichuan 614000, P.R. China

3. Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference29 articles.

1. Lung cancer statistics;Torre;Adv Exp Med Biol,2016

2. Lung cancer: Current therapies and new targeted treatments;Hirsch;Lancet,2017

3. Cancer progress and priorities: Lung cancer;Schabath;Cancer Epidemiol Biomarkers Prev,2019

4. Targeted therapy and checkpoint immunotherapy in lung cancer;Ruiz-Cordero;Surg Pathol Clin,2020

5. Cell death-based treatment of lung adenocarcinoma;Denisenko;Cell Death Dis,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of ORCs in predicting prognosis and immunotherapy outcomes: A pan-cancer analysis;Immunobiology;2024-03

2. Pick-up single-cell proteomic analysis for quantifying up to 3000 proteins in a Mammalian cell;Nature Communications;2024-02-10

3. Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma;PLOS ONE;2023-11-10

4. Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches;Cancers;2023-06-19

5. Phospholipases in human cancers: A new therapeutic target;Phospholipases in Physiology and Pathology;2023